Skip to main content
WST logo

WST · West Pharmaceutical Services Inc · Documents

Track WST — free
Market Cap
$29.01B
Shares
69.66M
Volume · Nov 16 106.26K Avg daily vol (3M) 601.93K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022
Feb 22
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $2.83B ▲ 31.9% Net income $661.8M ▲ 91.2% Diluted EPS $8.67 ▲ 89.7%
2021
Oct 28
Quarterly report 10-Q FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $706.5M ▲ 28.9% Net income $175.6M ▲ 113.4% Diluted EPS $2.31 ▲ 111.9%
Jul 30
Quarterly report 10-Q FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $723.6M ▲ 37.3% Net income $187.3M ▲ 105.4% Diluted EPS $2.47 ▲ 104.1%
Apr 30
Quarterly report 10-Q FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $670.7M ▲ 36.5% Net income $151.2M ▲ 103.5% Diluted EPS $1.99 ▲ 101.0%
Feb 23
Annual report 10-K FY2020, ended Dec 31
Annual report for FY2020
Revenue $2.15B ▲ 16.7% Net income $346.2M ▲ 43.2% Diluted EPS $4.57 ▲ 42.4%
2020
Oct 23
Quarterly report 10-Q FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $548M ▲ 20.1% Net income $82.3M ▲ 46.2% Diluted EPS $1.09 ▲ 45.3%
Jul 24
Quarterly report 10-Q FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $527.2M ▲ 12.2% Net income $91.2M ▲ 38.0% Diluted EPS $1.21 ▲ 37.5%
Apr 24
Quarterly report 10-Q FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $491.5M ▲ 10.8% Net income $74.3M ▲ 34.1% Diluted EPS $0.99 ▲ 35.6%
Feb 24
Annual report 10-K FY2019, ended Dec 31
Annual report for FY2019
Revenue $1.84B ▲ 7.1% Net income $241.7M ▲ 16.8% Diluted EPS $3.21 ▲ 17.2%
Showing 101–146 of 146 documents
Key facts CIK 105770 CUSIP 955306105 13F (30d) 681 filings 624 filers Visit website Investor relations